c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation

Mol Pharmacol. 1994 Jul;46(1):73-8.

Abstract

Down-regulation of c-myc mRNA expression is linked to growth arrest and the state of differentiation of hematopoietic cells. We showed that treatment of HL60 cells with suramin results in a rapid reduction of c-myc expression followed by an inhibition of cell growth. Both c-myc mRNA and protein levels decreased by day 1 of treatment, and, by day 4, only 10% of control c-myc protein levels were detected. In contrast to retinoic acid, dimethyl sulfoxide, and 12-O-tetradecanoylphorbol-13-acetate treatment, however, exposure of HL60 cells to suramin did not result in the induction of differentiation. These results demonstrate that suramin modulates c-myc levels in HL60 cells and that the down-regulation of c-myc is not sufficient to trigger differentiation toward either granulocytic or monocytic lineages.

MeSH terms

  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Division / drug effects
  • Cell Division / genetics
  • Down-Regulation*
  • Genes, myc*
  • Humans
  • Proto-Oncogenes
  • RNA, Messenger / metabolism
  • Suramin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • RNA, Messenger
  • Suramin